Medicare Enrolled
Dr. Vipul Desai, MD
Infectious Disease · The Woodlands, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desai
Dr. Vipul Desai is an infectious disease specialist in The Woodlands, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Desai performed 291,844 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Desai received a total of $113,140 from 51 pharmaceutical and/or device companies across 1494 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 1% volume in TX
$113,140 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗291,844
Medicare services
Top 1% in TX for infectious disease
Not available
Unique patients (not deduplicated)
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 214,177 | $0 | $0 |
| Injection, omadacycline, 1 mg | 38,801 | $3 | $6 |
| Dalbavancin injection, 5 mg An injection of the antibiotic dalbavancin, administered in a 5 mg dose. |
24,700 | $11 | $36 |
| Injection, meropenem, 100 mg | 6,089 | $0 | $3 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
2,207 | $47 | $132 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
1,887 | $0 | $3 |
| Ertapenem sodium injection, 500 mg An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg. |
1,517 | $10 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
657 | $92 | $280 |
| Anti-nausea injection (ondansetron/Zofran) | 566 | $0 | $1 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
324 | $22 | $65 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
290 | $132 | $387 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
219 | $15 | $39 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
171 | $11 | $44 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
128 | $15 | $42 |
| New patient office visit, complex (60-74 min) | 61 | $164 | $535 |
| Wound tissue removal, 20 sq cm or less This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less. |
30 | $74 | $125 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
20 | $17 | $58 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.0% high complexity
98.7% medium
0.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$113,140
Total received (2018-2024)
Avg $16,163/year across 7 years
Top 5% in TX for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
1,494
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$13,811
2023
$8,984
2022
$10,243
2021
$14,091
2020
$6,065
2019
$42,118
2018
$17,827
Payments by company (2024)
Cumberland Pharmaceuticals, Inc.
$10,304
Gilead Sciences, Inc.
$819
ViiV Healthcare Company
$675
ABBVIE INC.
$473
Astellas Pharma US Inc
$439
Merck Sharp & Dohme LLC
$245
Insmed, Inc.
$201
La Jolla Pharmaceutical Company
$196
Smith+Nephew, Inc.
$82
AIMMUNE THERAPEUTICS, INC.
$75
Melinta Therapeutics, LLC
$74
PFIZER INC.
$47
Shionogi Inc
$46
EMD Serono, Inc.
$45
Ferring Pharmaceuticals Inc.
$29
Paratek Pharmaceuticals, Inc.
$24
TerSera Therapeutics LLC
$22
ETS Wound Care LLC
$15
Top 3 companies account for 85.4% of 2024 payments
All-time payments by company (2018-2024) ›
Melinta Therapeutics, Inc.
$41,698
Cumberland Pharmaceuticals, Inc.
$15,322
Paratek Pharmaceuticals, Inc.
$13,043
Allergan Inc.
$7,468
Ferring Pharmaceuticals Inc.
$5,387
Gilead Sciences, Inc.
$4,740
CIPLA USA INC.
$4,541
TETRAPHASE PHARMACEUTICALS, INC.
$4,396
ViiV Healthcare Company
$2,872
Insmed, Inc.
$1,668
Astellas Pharma US Inc
$1,395
Allergan, Inc.
$1,361
Smith+Nephew, Inc.
$1,057
AbbVie Inc.
$1,037
ABBVIE INC.
$968
Merck Sharp & Dohme Corporation
$945
Shionogi Inc
$746
Melinta Therapeutics, LLC
$617
Merck Sharp & Dohme LLC
$598
La Jolla Pharmaceutical Company
$499
GRT US Holding, Inc.
$416
Osiris Therapeutics Inc.
$380
Janssen Biotech, Inc.
$245
Theravance Biopharma, Inc.
$238
EMD Serono, Inc.
$200
PFIZER INC.
$136
Theratechnologies Inc.
$133
MAYNE PHARMA INC.
$104
SANOFI-AVENTIS U.S. LLC
$101
Endo Pharmaceuticals Inc.
$97
AIMMUNE THERAPEUTICS, INC.
$75
Janssen Products, LP
$70
ORGANOGENESIS INC.
$69
Abbott Laboratories
$67
Dynavax Technologies Corporation
$49
Vyera Pharmaceuticals, LLC
$43
Octapharma USA, Inc.
$41
Napo Pharmaceuticals Inc
$41
Imbed Biosciences Inc.
$36
KCI USA, Inc
$31
PORTOLA PHARMACEUTICALS, INC.
$29
Mayne Pharma Inc.
$28
Tactile Systems Technology Inc
$23
TerSera Therapeutics LLC
$22
Mylan Pharmaceuticals Inc.
$20
ConvaTec Inc.
$17
CSL Behring
$16
ETS Wound Care LLC
$15
Organogenesis Inc.
$15
Nabriva Therapeutics, plc
$14
Seqirus USA Inc
$11
Top 3 companies account for 61.9% of all-time payments
Associated products mentioned in payments ›
AMBISOME · APRETUDE · AQUACEL AG+ · AVYCAZ · Arikayce · BEVYXXA · Baxdela · Biktarvy · CABENUVA · COLLAGENASE SANTYL · CRESEMBA · Cresemba · DALVANCE · DELSTRIGO · DIFICID · DORYX · DOVATO · Daraprim Tablet 25mg · EGRIFTA · FLEXITOUCH · Fetroja · Fluad · GRAFIX · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · Grafix CORE · Grafix PL PRIME · GrafixPL · Heplisav-B · ISENTRESS · JULUCA · Kimyrsa · LEXISCAN · MAVYRET · MIRRAGEN ADVANCED WOUND MATRIX · MYCAMINE · Mytesi · NASCOBAL · NOXAFIL · NUZYRA · Oasis · Orbactiv · PANZYGA · PICO 7 Single Use Negative Pressure Wound Therapy · PICO7 · PIFELTRO · PRALUENT · PREVNAR 20 · PREVYMIS · PREZCOBIX · PREZISTA · Privigen · Proclaim IPG · Puraply · Qutenza · Quzyttir · REBYOTA · REGRANEX · RENASYS · SEROSTIM · SILVERCEL · SNAP · SYMTUZA · Santyl · Serostim · Stravix · Symfi Lo · Symtuza · TEFLARO · TRIUMEQ · TROGARZO · TRUMENBA · VIBATIV · VOWST · Vabomere · Veklury · Veozah · Vibativ · XERAVA · Xenleta · Xerava · ZEMDRI (PLAZOMICIN) · ZERBAXA · ZINPLAVA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Infectious diseases in nearby ZIP areas
34
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Desai is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Desai experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Desai performed 214,177 daptomycin antibiotic injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $113,140 from 51 companies across 1,494 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other infectious diseases in The Woodlands?
Dr. Desai's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in The Woodlands
Browse infectious diseases in The Woodlands ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in TX
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in TX
Which TX infectious diseases receive the most from drug and device companies.
By company
Melinta Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Melinta Therapeutics, Inc.
By company
Cumberland Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Cumberland Pharmaceuticals, Inc.
By company
Paratek Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Paratek Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology